期刊文献+

钙反应性反式激活因子在肌萎缩侧索硬化症转基因鼠中的表达及意义

Expression of calcium-responsive transactivator in ALS transgenic mice
下载PDF
导出
摘要 目的探讨钙反应性反式激活因子(CREST)在肌萎缩侧索硬化症(ALS)转基因鼠脊髓及脑干组织中的表达变化及相关性作用。方法分别取出生后95 d、108 d、122 d(早、中、晚期)野生型与SOD1-G93A转基因鼠,通过RT-PCR、蛋白免疫印迹技术检测脊髓组织中CREST mRNA及蛋白水平表达变化,通过免疫荧光双标记技术检测脊髓及脑干组织中CREST的表达变化及与神经元及星形胶质细胞的共表达情况。结果 (1)与野生型鼠相比较,SOD1-G93A转基因鼠脊髓组织中CREST蛋白水平下调(P<0.05),在mRNA水平变化并不明显。(2)免疫荧光双标检测显示,CREST主要表达于细胞核,与神经元有共表达,与星形胶质细胞不存在共表达;与野生型鼠比较,SOD1-G93A转基因鼠脊髓和脑干组织中CREST表达下调(P<0.05)。结论 CREST的差异表达可能与ALS运动神经元的功能障碍有关。 Objective To investigate the expression of calcium-responsive transactivator( CREST) in the spinal cord and brainstem of ALS transgenic mice,and explore the role and significance of CREST in the pathogenesis of ALS. Methods The mRNA and protein level of CREST were detected by RT-PCR and Western blot in the spinal cord of ALS transgenic mice at the different stages of disease( post-natal 95 d,108 d and 122 d). The immunofluorescence was used to detect the coexpression of CREST/β-tubulin III and CREST/GFAP in the spinal cord and brain stem.Results Compared with that of wild type mice,the protein level of CREST in the spinal cord tissue was down-regulated( P〈0. 05),but not significant at mRNA level. CREST was mainly expressed in the nucleus. CREST-positive cells were also β-tubulin III positive but GFAP negative. Compared with that of wild-type mice,CREST level of SOD1-G93 A transgenic mice in the spinal cord and brain stem was downregulated( P〈0.05).Conclusions The differential expression of CREST may be related to the dysfunction of motor neurons in ALS.
出处 《中国老年学杂志》 CAS 北大核心 2017年第17期4177-4179,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金青年基金(81271413 81401066) 山东省科技发展计划项目(2012GSF11827) 山东省自然科学基金(ZR2012HQ021) 山东省教育厅课题(J12LK51 J13LK05) 山东省医药卫生科技发展计划项目(2013WS0279)
关键词 钙反应性反式激活因子 肌萎缩侧索硬化症 Calcium-responsive transactivator ALS
  • 相关文献

参考文献2

二级参考文献26

  • 1Kiernan MC,Vucic S,Cheah BC,et al.Amyotrophic lateral sclerosis[J].Lancet,2011,377(9769):942-955.
  • 2Tripathi VB,Al-Chalabi A.Molecular insights and therapeutic targets in amyotrophic lateral sclerosis[J].CNS Neurol Disord Drug Targets,2008,7(1):11-19.
  • 3Gurney ME,Liu R,Althaus JS,et al.Mutant Cu/Zn superoxide dismutase in motor neuron disease[J].J Inherit Metab Dis,1998,21(5):587-597.
  • 4Rocha JA,Reis C,Sim(o)es F,et al.Diagnostic investigation and multidisciplinary management in motor neuron disease[J].J Neurol,2005,252(12):1435-1447.
  • 5Inestrosa NC,Varela-Nallar L,Grabowski CP,et al.Synaptotoxicity in Alzheimer's disease:the Wnt signaling pathway as a molecular target[J].IUBMB Life,2007,59(4-5):316-321.
  • 6He B,Reguart N,You L,et al.Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations[J].Oncogene,2005,24(18):3054-3058.
  • 7Hsieh JC,Kodjabachian L,Rebbert ML,et al.A new secreted protein that binds to Wnt proteins and inhibits their activities[J].Nature,1999,398 (6726):431-436.
  • 8Shi P,Wei Y,Zhang J,et al.Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis[J].J Alzheimers Dis,2010,20(Suppl 2):S311-S324.
  • 9Rosen DR,Siddique T,Patterson D,et al.Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis[J].Nature,1993,362(6415):59-62.
  • 10Marx J.Mouse model found for ALS[J].Science,1994,264(5166):1663-1664.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部